###begin article-title 0
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Enhanced susceptibility of cyclin kinase inhibitor p21 knockout mice to high fat diet induced atherosclerosis
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 238 242 238 242 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 503 507 488 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 579 583 564 568 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 751 755 736 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 963 967 945 949 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1107 1111 1083 1087 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1172 1176 1142 1146 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 1239 1243 1209 1213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1347 1351 1317 1321 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 222 227 <span type="species:ncbi:10090">mouse</span>
###xml 271 275 <span type="species:ncbi:10090">mice</span>
###xml 583 587 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 967 971 <span type="species:ncbi:10090">mice</span>
###xml 1111 1115 <span type="species:ncbi:10090">mice</span>
###xml 1243 1247 <span type="species:ncbi:10090">mice</span>
###xml 1274 1278 <span type="species:ncbi:10090">mice</span>
###xml 1373 1377 <span type="species:ncbi:10090">mice</span>
###xml 1514 1518 <span type="species:ncbi:10090">mice</span>
Cyclin kinase inhibitor p21 is one of the most potent inhibitors of aortic smooth muscle cell proliferation, a key mediator of atherosclerosis. This study tests if p2l deficiency will result in severe atherosclerosis in a mouse model. p21-/- and strain matched wild type mice were fed with high fat diet for 21 weeks. Analysis for biochemical parameters (cholesterol, triglycerides) in serum and mRNA expression of CD36, HO-1, TGF-beta, IFN-gamma, TNF-alpha, PPAR-gamma and NADPH oxidase components (p22phox, NOX-1 and Rac-1) was performed in aortic tissues by Real Time PCR. p21-/- mice gained significantly (p < 0.01) more weight than wild type mice, triglycerides (p < 0.05) and cholesterol levels (p < 0.01) were more pronounced in the sera of p21-/- compared to wild type mice fed with high fat diet. High fat diet resulted in significantly decreased TGF-beta (p < 0.02), HO-l (p < 0.02) and increased CD36 (p < 0.03) mRNA expression in aortic tissues of p21-/- mice compared to animal fed with regular diet. IFN-gamma mRNA expression (235 +/- 11 folds) increased significantly in high fat diet fed p21-/- mice and a multifold modulation of PPAR-gamma(136 +/- 7), p22phox, NOX-1 and Rac-1 (15-35-folds) mRNA in aortic tissues from p21-/- mice compared to the wild type mice. Severity of atherosclerotic lesions was significantly higher in p21-/- compared to wild type mice. The results demonstrate that the deficiency of p21 leads to altered expression of pro-atherogenic genes, and severe atherosclerosis in mice fed with high fat diet. This opens the possibility of p21 protein as a therapeutic tool to control progression of atherosclerosis.
###end p 2
###begin title 3
Introduction
###end title 3
###begin p 4
###xml 216 217 216 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 218 219 218 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 723 724 720 721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 772 773 769 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 774 775 771 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 840 841 837 838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1195 1196 1183 1184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1197 1199 1185 1187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 1298 1300 1286 1288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 1301 1303 1289 1291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1587 1589 1569 1571 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1802 1804 1778 1780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1915 1917 1891 1893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2056 2058 2029 2031 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 2503 2505 2473 2475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 2747 2749 2717 2719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 2750 2752 2720 2722 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2844 2846 2814 2816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 2899 2901 2869 2871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 2902 2904 2872 2874 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 3025 3029 2995 2999 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 3189 3193 3148 3152 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 3029 3033 <span type="species:ncbi:10090">mice</span>
Atherosclerosis is one of the major causes of death in the modern world. Despite large efforts, its pathogenesis remains largely unclear. More recently, atherosclerosis is considered to be a disease of inflammation [1-4]. The precise events leading to inflammation/immune activation in atherosclerosis are not fully understood. Aberrant proliferation of smooth muscle cells is one of the key factors in the pathogenesis of atherosclerosis. Therefore, molecules that control cellular proliferation play a significant role in the understanding of underlying mechanisms of the pathogenesis of atherosclerosis. Transforming growth factor-beta (TGF-beta) is one of the most potent inhibitor of smooth muscle cell proliferation [5], its expression decreases in atherosclerosis [6,7], highlighting its role in the pathogenesis of atherosclerosis [8]. Besides, these reported protective effects of TGF-beta, its role in atherosclerosis is controversial because studies have demonstrated a causative role of TGF-beta in the pathogenesis of atherosclerosis is reported based on the studies, which demonstrate that active TGF-beta in smooth muscle cells promote lipid accumulation via increased synthesis [9-11] and deposition of proteoglycan in intima, known to be associated with increased atherosclerosis [12,13]. In another study, TGF-beta expression was considered to be a determinant for the extent to which developing atherosclerotic lesions are stabilized by a collagen-rich fibrous cap and higher levels of TGF-beta in SMC of stable lesions compared to the unstable lesions were observed [14]. These studies suggest that the role of TGF-beta may be detrimental in atherosclerosis. Studies have shown that TGF-beta induces expression of cyclin kinase inhibitor p21, which mediates its inhibitory effects [15]. Overexpression of p21 has been shown to reverse atherosclerosis in experimental models of atherosclerosis. [16]. In addition to inducing expression of protective molecules like p21, TGF-beta also inhibits the expression of CD36, a scavenger of LDL [17]. We have earlier demonstrated 5 that the aberrant proliferation of smooth muscles due to the deletion of TGF-beta gene was restored by p21. Therefore, it suggests that p21 play a significant role in the control of aberrant proliferation of smooth muscle cells, an essential event in the pathogenesis of atherosclerosis. Furthermore, the protective role of heme oxygenase-1 (HO-1) in atherosclerosis is also attributed to its induction of p21 [18]. Similarly, other studies have demonstrated that the positive effects of HO-1 are associated with increased expression of p21 that promotes the inhibition of smooth muscle cell proliferation and provides protection against atherosclerosis [19-21]. Also, atherosclerosis is considered to be due to a state of heightened oxidative stress [22] and p21 provides protection from oxidative stress [23,24]. Therefore, these studies were performed to understand the role of p21 on the pathogenesis of atherosclerosis using p21-/- mice. The animals were fed either a high fat or regular diet. Aortic expression of TGF-beta, CD36, HO-1, IFN-gamma, PPAR-gamma and NADOH oxidase components (p22phox, NOX-1 and Rac-1) was studied and histopathology was quantified. The results demonstrate that the modulation of p21 can assist in dissecting the events leading to the initiation and development of atherosclerosis.
###end p 4
###begin title 5
Materials and methods
###end title 5
###begin title 6
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice and treatment
###end title 6
###begin p 7
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 254 258 254 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 184 188 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
Mice (6 weeks old) lacking p21 (p21-/-) were bred from a breeding pair generously provided by Dr. Philip Leder, Howard Hughes Medical Institute, Boston. Strain matched (FVB) wild type mice were purchased from Taconic Labs. Wild-type (6 weeks old) and p21-/- mice (24 each) were fed initially with regular diet, which consisted of <0.05% cholesterol, approximately 5% of animal fat without casein or sodium cholate, and then were fed with a standard atherogenic diet. The high-cholesterol diet from Dyets Inc. Bethlehem, PA USA) were used. The high cholesterol diet was continued for 21 weeks when a peak of atherosclerosis is achieved. All studies were performed with approved institutional IACUC protocols.
###end p 7
###begin title 8
Lipid profile
###end title 8
###begin p 9
Sera was separated and stored at -80degreesC until analysis. Using specific kits from Wako Chemicals Richmond, VA, USA, levels of total cholesterol and triglycerides were quantified from sera samples obtained at study endpoint (21 weeks of high cholesterol diet)..
###end p 9
###begin title 10
Analysis of mRNA expression of pro-and anti-atherogenic intermediates in atherosclerosis
###end title 10
###begin p 11
###xml 494 504 486 493 <bold xmlns:xlink="http://www.w3.org/1999/xlink">TGF-&#946;; </bold>
###xml 579 583 568 572 <bold xmlns:xlink="http://www.w3.org/1999/xlink">CD36</bold>
###xml 660 664 649 653 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HO-1</bold>
###xml 744 754 733 740 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin</bold>
###xml 851 861 837 843 <bold xmlns:xlink="http://www.w3.org/1999/xlink">IFN-&#947; </bold>
###xml 939 942 921 924 <bold xmlns:xlink="http://www.w3.org/1999/xlink">p22</bold>
###xml 942 947 924 929 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox </sup>
###xml 1021 1026 1003 1008 <bold xmlns:xlink="http://www.w3.org/1999/xlink">NOX-1</bold>
###xml 1105 1110 1087 1092 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Rac-1</bold>
###xml 1190 1201 1172 1180 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#946;-actin </bold>
###xml 2065 2069 2014 2018 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2069 2073 <span type="species:ncbi:10090">mice</span>
We performed real-time quantitative RT-PCR for IFN-gamma, PPAR-gamma and NADPH oxidase components (p22phox, NOX-1 and Rac-1) mRNA using a Bio-Rad iCycler system (Bio-Rad, Hercules, CA). RNAs were isolated from cardiac l tissues using a kit from Promega (Madison, USA) and reverse-transcribed into cDNAs by using a cDNA synthesis kit from invitrogen (Carlsbad CA). The amplification of specific mRNA expression was achieved by polymerase chain reaction (PCR) using specific primer sequences for TGF-beta; sense: 5'-GGGACTA TCCACCTGCAAGA-3'; antisense: 5'-CACGTGCTGCTCCACTTTTA-3'; CD36; sense: 5'-AGATGCA GCCTCATTTCCAC-3'; antisense: 5'-GCCTTGGATGGAAGAACAAA-3'; HO-1; sense: 5'-TCCGATGGGTCCTTACACTC-3'; antisense: 5'-ATTGCCTGGATGTGCTTT TC-3' and beta-actin; sense: 5'-TGACGGGGTCACCC ACACTGTGAACATCTA-3'; antisense, 5'-CTTGAAGCATTTGCGGTGGACGATGGAGGG-3'; IFN-gamma sense 5'-TCTGGAGGAACTG GCAAAAG-3', antisense 5'-TTCAAGACTTCAAAGAGTC TGAGG-3'; p22phox sense 5'-G CCATTGCCAGTGTGATCTA-3'; antisense: 5'-AATGGGAGTCCACTGCTCAC-3'; NOX-1; sense: 5'-GGCATCCCTTTACTCTG ACCT-3'; antisense: 5'-TGCTGCTCGAATATGAA TGG-3'; Rac-1; sense: 5'-GTA CATCCCCACCGTCTTTG-3'; antisense: 5'-CCCAGATTC ACTGGTTTTC-3' and beta-actin sense: 5'-CCCAGCACAATGA AGATCAA-3' and antisense 5'-CG ATCCACACGGAGTACTTG-3. The primers were tested by running a regular PCR for 40 cycles at 95degreesC for 20 s and 60degreesC for 1 minute, and followed separating in ethidium bromide containing agarose gels. The real-time PCR was performed using a SYBR supermix kit (Bio-RAD), and running for 40 cycles at 95degreesC for 20 s and 60degreesC for 1 minute. The PCR efficiency was also examined by serially diluting the template cDNA and the melting curve data was collected to check the PCR specificity and proper negative controls were included in each assay. The mRNA level for each gene for each sample was normalized to beta-actin mRNA and quantified using a formula; 2 [(Ct/beta-actin - Ct/gene of interest)]. The results are expressed as fold difference in high fat diet fed compared to regular diet fed p21-/- mice.
###end p 11
###begin title 12
Histology and Morphometry
###end title 12
###begin p 13
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 378 380 378 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 660 665 <span type="species:ncbi:10090">mouse</span>
The differences among the high cholesterol fed wild-type mice and p21-/- mice regarding atherogenesis was evaluated quantitatively by microscopic examination the atherosclerotic lesions. Serial cross-sections at least in triplicate were cut through the aortic coronary artery region, beginning with the appearance of all three-valve cusps as described by Daugherty and Whitman [25]. The sections were stained with Hematoxylin-and-eosin and Oil Red O, and counter-stained with hemalum. The quantification of the atherosclerotic lesions was made by using an Olympus microscope and by computer-aided morphometry software Image J. The average lesion size for each mouse were calculated and converted in to percent of total area counted. Statistical analysis was performed by the use of statistical software (GraphPad, San Diego).
###end p 13
###begin title 14
Data analysis
###end title 14
###begin p 15
Differences between groups were determined using two-tailed unpaired T test with significance considered present at a p value of less than 0.05. Statistical analysis was performed using a software program from GraphPad Software, Inc., San Diego, CA 92121 USA. The results are expressed as Mean +/- SEM.
###end p 15
###begin title 16
Results
###end title 16
###begin title 17
Weight gain
###end title 17
###begin p 18
###xml 129 133 125 129 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 260 264 252 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 368 370 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 327 331 <span type="species:ncbi:10090">mice</span>
Wild-type mice gained weight (22 +/- 1.2 g vs 35 +/- 1.5 g, p < 0.01) when fed with high fat diet, however weight gain in and p21-/- was significantly higher (24 +/- 1 vs 46.4 +/- 2.3 g, p < 0.001) when fed with high fat diet. Interestingly, weight gain in p21-/- mice was significantly higher (p < 0.01) compared to wild-type mice also fed with high fat diet (Figure 1A).
###end p 18
###begin p 19
###xml 75 79 75 79 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 105 0 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Body weight (BW), plasma cholesterol, and plasma triglyceride levels in p21<sup>-/- </sup>and wild type control mice</bold>
###xml 107 108 107 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 195 199 195 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 266 270 264 268 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 316 320 314 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 390 391 388 389 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 526 530 524 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 101 105 <span type="species:ncbi:10090">mice</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 361 365 <span type="species:ncbi:10090">mice</span>
###xml 544 548 <span type="species:ncbi:10090">mice</span>
Body weight (BW), plasma cholesterol, and plasma triglyceride levels in p21-/- and wild type control mice. A: Differential effect of high fat diet on weight gain in wild type mice (n = 8) and p21-/- (n = 8) mice is shown. Values are means +/- SEM, Weight gain in p21-/- mice fed with high fat diet is compared to p21-/- mice fed with regular diet and wild type mice fed with high fat diet. B: Differential effect on the effect of high fat diet on plasma levels of cholesterol (open bars) and triglycerides (closed bars) in p21-/- and wild type mice fed with high fat and regular diet is shown.
###end p 19
###begin title 20
Triglycerides and Cholesterol Levels
###end title 20
###begin p 21
###xml 34 38 34 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 248 250 248 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 474 478 470 474 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 688 692 680 684 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1016 1020 1004 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1238 1242 1222 1226 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 38 42 <span type="species:ncbi:10090">mice</span>
###xml 203 207 <span type="species:ncbi:10090">mice</span>
###xml 297 301 <span type="species:ncbi:10090">mice</span>
###xml 337 341 <span type="species:ncbi:10090">mice</span>
###xml 478 482 <span type="species:ncbi:10090">mice</span>
###xml 692 696 <span type="species:ncbi:10090">mice</span>
###xml 832 836 <span type="species:ncbi:10090">mice</span>
###xml 872 876 <span type="species:ncbi:10090">mice</span>
###xml 1020 1024 <span type="species:ncbi:10090">mice</span>
###xml 1242 1246 <span type="species:ncbi:10090">mice</span>
These results demonstrate that p21-/- mice compared to their wild type counterparts were more prone to the effects of high fat diet. Circulating levels of cholesterol and triglycerides levels in sera of mice from each group were quantified (Figure 1B). Triglycerides levels increased in wild-type mice fed with high fat diet compared to mice fed with regular diet (11-+/- 3 vs 21 +/- 2 mg/dl). However, the increase of triglycerides levels was more pronounced in sera of p21-/- mice fed with high fat diet compared to regular diet (19 +/- 2.5 vs 41 +/- 6 mg/dl p < 0.001). A significant (p < 0.05) increase in triglycerides levels was observed when we compared levels of wild-type and p21-/- mice. Similar results were obtained with quantification of cholesterol levels. The circulating levels of cholesterol increased in wild-type mice fed with high fat diet compared to mice fed with regular diet (31 +/- 4 vs 60 +/- 4 mg/dl p < 0.05). However, the increase of cholesterol levels was more pronounced in sera of p21-/- mice fed with high fat diet compared to regular diet (42 +/- 6 vs 88 +/- 11 mg/dl p < 0.001). A significant (p < 0.05) increase in circulating levels of cholesterol was observed when levels in sera of wild-type and p21-/- mice fed with high fat diet were compared.
###end p 21
###begin title 22
###xml 113 117 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 117 121 <span type="species:ncbi:10090">mice</span>
Effect of high fat diet on mRNA expression of anti-atherogenic (TGF-beta, HO-1) and pro-atherogenic (CD36) in p21-/- mice
###end title 22
###begin title 23
TGF-beta mRNA expression
###end title 23
###begin p 24
###xml 260 264 254 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 371 373 362 364 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 382 386 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 518 522 506 510 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 53 57 <span type="species:ncbi:10090">mice</span>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
###xml 264 268 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 654 658 <span type="species:ncbi:10090">mice</span>
###xml 671 675 <span type="species:ncbi:10090">mice</span>
The expression of TGF-beta mRNA in aortic tissues of mice fed with high fat diet was compared in mice fed with high fat and regular diet. Total RNA from aortic tissues was reverse transcribed to cDNA and amplified for TGF-beta mRNA by PCR. In wild-type and p21-/- mice, TGF-beta mRNA expression decreased though in wild-type mice the decrease was not significant (Figure 2A). In p21-/- mice a highly significant (p < 0.02) decrease was observed. We also have data on TGF-beta mRNA expression in aortic tissues from p21-/- mice fed with regular or high fat diet. A highly significant (p < 0.01) decrease in TGF-beta mRNA was observed in high fat diet fed mice compared to mice fed with regular diet [Relative TGF-beta mRNA expression (M +/- SEM) n = 4, .5 +/- 0.4 vs 3.6 +/- 0.3).
###end p 24
###begin p 25
###xml 44 48 44 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 74 0 74 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Atherogenesis related gene expression in p21<sup>-/- </sup>and wild type control mice</bold>
###xml 148 149 145 146 <bold xmlns:xlink="http://www.w3.org/1999/xlink">A</bold>
###xml 158 159 155 156 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 192 193 189 190 <bold xmlns:xlink="http://www.w3.org/1999/xlink">C</bold>
###xml 268 272 263 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 272 276 <span type="species:ncbi:10090">mice</span>
Atherogenesis related gene expression in p21-/- and wild type control mice. Intra-aortic analysis of mRNA expression for anti-atherogenic TGF-beta (A), HO-1 (B) and pro-atherogenic gene CD36 (C) is shown. Values presented are means +/- SEM in wild type (n = 8) and p21-/- mice (n = 8) fed with regular and high fat diet.
###end p 25
###begin title 26
CD36 mRNA expression
###end title 26
###begin p 27
###xml 226 230 226 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 277 281 277 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 348 350 348 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 448 452 448 452 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 230 234 <span type="species:ncbi:10090">mice</span>
###xml 281 285 <span type="species:ncbi:10090">mice</span>
###xml 374 378 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 502 506 <span type="species:ncbi:10090">mice</span>
Based on its role in the pathogenesis of atherosclerosis, it was hypothesized that the expression of CD36 mRNA in aortic tissues of mice fed with high fat diet will be more than mice fed with regular diet. In wild-type and p21-/- mice, CD36 mRNA expression increased but in p21-/- mice a highly significant (p < 0.03) increase was observed (Figure 2B) compared to wild type mice. The expression of CD36 mRNA was significantly more (p < 0.05) in p21-/- mice fed with high fat diet compared to wild-type mice also fed with high fat diet.
###end p 27
###begin title 28
HO-1 mRNA expression
###end title 28
###begin p 29
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 311 315 311 315 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 361 365 361 365 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 433 435 433 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 106 110 <span type="species:ncbi:10090">mice</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 315 319 <span type="species:ncbi:10090">mice</span>
###xml 365 369 <span type="species:ncbi:10090">mice</span>
HO-1 has been shown to be protective in atherosclerosis, therefore, mRNA expression was studied in p21-/- mice fed with high fat diet and compared to wild-type mice fed with similar diet. Total RNA from aortic tissues was reverse transcribed to cDNA and amplified for HO-1 mRNA by PCR. In both wild-type and p21-/- mice HO-1 mRNA expression decreased but in p21-/- mice a highly significant (p < 0.002) decrease was observed (Figure 2C).
###end p 29
###begin title 30
###xml 101 105 93 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 130 134 122 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 134 138 <span type="species:ncbi:10090">mice</span>
Effect of high fat diet on mRNA expression of IFN-gamma, PPAR-gamma and NADPH oxidase components (p22phox, NOX-1 and Rac-1) in p21-/- mice
###end title 30
###begin p 31
###xml 96 100 88 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 239 241 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 387 391 373 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 475 477 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 743 747 723 727 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 850 852 826 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 100 104 <span type="species:ncbi:10090">mice</span>
###xml 391 395 <span type="species:ncbi:10090">mice</span>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 747 751 <span type="species:ncbi:10090">mice</span>
###xml 794 798 <span type="species:ncbi:10090">mice</span>
###xml 956 961 <span type="species:ncbi:9606">human</span>
IFN-gamma mRNA expression was studied by Real time PCR analysis. IFN-gamma mRNA increased in p21-/- mice fed with high fat diet compared to those fed with regular diet. These results amplification peaks in a real time PCR reaction (Figure 3A) show that IFN-gamma mRNA was detectable at a very low levels in regular diet fed group compared to significantly higher (236 +/- 11 fold) in p21-/- mice compared to (12 +/- 1.6 fold) in wild type mice fed with high fat diet (Figure 3B). To understand the role of peroxisome proliferator-activated receptors (PPARs) in the development of atherosclerosis, the expression patterns of mRNA of PPAR-gamma in aortic tissues from mice was investigated. Higher PPAR-gamma mRNA was detected in aortas from p21-/- mice (136 +/- 7.3-folds) compared to wild type mice (15 +/- 2.7) fed with either high fat diet (Figure 3C). PPAR-gamma is likely to be an important regulator of monocyte/macrophage function with relevance for human atherosclerotic disease.
###end p 31
###begin p 32
###xml 87 91 79 83 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 136 140 128 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 144 0 136 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitative mRNA expression of IFN-&#947;, PPAR-&#947; and NADPH oxidase components (p22<sup>phox</sup>, NOX-1 and Rac-1) in aortic tissues from p21<sup>-/- </sup>mice</bold>
###xml 337 338 325 326 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 353 354 337 338 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 402 406 386 390 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 140 144 <span type="species:ncbi:10090">mice</span>
###xml 209 213 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
Quantitative mRNA expression of IFN-gamma, PPAR-gamma and NADPH oxidase components (p22phox, NOX-1 and Rac-1) in aortic tissues from p21-/- mice. Amplification curves for IFN-g in RNA isolated from aorta from mice fed with high fat diet (HFD) and regular diet (RGD) are shown. Significantly higher Relative fold expression of IFN-gamma (B), PPAR-gamma (B) mRNA is shown in Wild type (open bars) and p21-/- mice (closed bars). The values are means +/- SEM of fold increase in high fat diet compared to the results obtained from mice fed with regular diet.
###end p 32
###begin p 33
###xml 78 79 78 79 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 102 106 102 106 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 247 251 241 245 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 251 255 <span type="species:ncbi:10090">mice</span>
###xml 311 315 <span type="species:ncbi:10090">mice</span>
The results of mRNA expression of NADPH oxidase components is shown in Figure 4, the expression of p22phox, NOX-1 and Rac-1 increased 29 +/- 1.6, 32 +/- 2.1 and 15.6 +/- 1.2 folds, respectively in high fat diet fed compared to regular diet fed p21-/- mice. Significantly lower values were observed in wild type mice (data not shown).
###end p 33
###begin p 34
###xml 61 65 61 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 110 114 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 0 118 0 118 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitative mRNA expression of NADPH oxidase components (p22<sup>phox</sup>, NOX-1 and Rac-1) in aortic tissues from p21<sup>-/- </sup>mice</bold>
###xml 183 187 183 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 266 270 266 270 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 114 118 <span type="species:ncbi:10090">mice</span>
###xml 270 274 <span type="species:ncbi:10090">mice</span>
###xml 331 335 <span type="species:ncbi:10090">mice</span>
Quantitative mRNA expression of NADPH oxidase components (p22phox, NOX-1 and Rac-1) in aortic tissues from p21-/- mice. The results of mRNA expression of NADPH oxidase components; p22phox, NOX-1 and Rac-1 are shown as fold increase in high fat diet (HFD) treated p21-/- mice (n = 8) using results from regular diet (n = 8) treated mice as controls (RGD).
###end p 34
###begin title 35
Histopathological Analysis
###end title 35
###begin p 36
###xml 107 109 107 109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 154 158 154 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 187 188 187 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 212 216 212 216 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 244 245 244 245 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 289 290 289 290 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 401 413 401 413 <bold xmlns:xlink="http://www.w3.org/1999/xlink">black arrows</bold>
###xml 528 532 528 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 892 896 882 886 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 909 911 899 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
###xml 158 162 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 260 264 <span type="species:ncbi:10090">mice</span>
###xml 532 536 <span type="species:ncbi:10090">mice</span>
###xml 896 900 <span type="species:ncbi:10090">mice</span>
The histological analysis of cross-sections cut through the aortic coronary artery region are shown Figure 5A. The results shows marked differences in p21-/- mice fed with high fat diet (d) either compared to p21-/- mice fed with regular diet (c) or wild type mice fed with high fat diet (a), a low power view of a coronary artery showing narrowing of the lumen by atheromatous plaque and scar areas (black arrows) are shown. The score of lesions are expressed as the percent lesions, quantified in aortas from wild type and p21-/- mice fed with either regular diet or high fat diet and expressed as mean +/- SEM. Percent area with aortic lesions was higher (4 +/- 0.4% vs 10.2 +/- 0.3%, p < 0.01) in wild type fed with high fat diet compared to regular diet. However, the extent of severity of atherosclerotic lesions was significantly more (8.4 +/- 0.6% vs 30.9 +/- 0.8%, p < 0.0001) in p21-/- mice (Figure 5B).
###end p 36
###begin p 37
###xml 0 53 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Histology and morophometry of atherosclerotic lesions</bold>
###xml 158 162 158 162 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 326 327 326 327 <bold xmlns:xlink="http://www.w3.org/1999/xlink">a</bold>
###xml 345 346 345 346 <bold xmlns:xlink="http://www.w3.org/1999/xlink">b</bold>
###xml 352 356 352 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 384 385 384 385 <bold xmlns:xlink="http://www.w3.org/1999/xlink">c</bold>
###xml 406 407 406 407 <bold xmlns:xlink="http://www.w3.org/1999/xlink">d</bold>
###xml 419 432 419 432 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Black arrows </bold>
###xml 469 470 469 470 <bold xmlns:xlink="http://www.w3.org/1999/xlink">B</bold>
###xml 659 663 657 661 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 298 302 <span type="species:ncbi:10090">mice</span>
###xml 356 360 <span type="species:ncbi:10090">mice</span>
###xml 529 534 <span type="species:ncbi:10090">mouse</span>
###xml 600 604 <span type="species:ncbi:10090">mice</span>
###xml 663 667 <span type="species:ncbi:10090">mice</span>
Histology and morophometry of atherosclerotic lesions. Photomicrographs of light microscopy of representative sections of the coronary artery tissues from p21-/- and wild type mice. Magnification is x20 for all tissues. Haematoxylin and eosin staining of in the coronary artery issues of wild type mice fed with regular diet (a), high fat diet (b); p21-/- mice fed with regular diet (c) and high fat diet (d) is shown. Black arrows indicate areas with scar. The graph (B) shows the mean lesion area (values are Mean +/- SEM) per mouse. *p < 0.01, high fat diet (HFD) vs regular diet (RGD), wild type mice and **p < 0.0001, high fat diet vs regular diet in p21-/- mice.
###end p 37
###begin title 38
Discussion
###end title 38
###begin p 39
###xml 48 52 48 52 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 234 238 234 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 364 368 364 368 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 625 629 622 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 817 821 811 815 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 972 976 966 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1643 1645 1634 1636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 1646 1648 1637 1639 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 2417 2421 2405 2409 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2588 2590 2576 2578 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 2648 2650 2633 2635 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 2651 2653 2636 2638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 2940 2944 2919 2923 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
###xml 368 372 <span type="species:ncbi:10090">mice</span>
###xml 409 413 <span type="species:ncbi:10090">mice</span>
###xml 643 647 <span type="species:ncbi:10090">mice</span>
###xml 743 747 <span type="species:ncbi:10090">mice</span>
###xml 821 825 <span type="species:ncbi:10090">mice</span>
###xml 866 870 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
###xml 1021 1025 <span type="species:ncbi:10090">mice</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
###xml 2237 2241 <span type="species:ncbi:10090">mice</span>
###xml 2388 2392 <span type="species:ncbi:10090">mice</span>
###xml 2421 2425 <span type="species:ncbi:10090">mice</span>
###xml 2944 2948 <span type="species:ncbi:10090">mice</span>
The results from this study demonstrate that p21-/- mice exhibited tendency towards increased atherosclerosis when fed with high fat diet. This included significantly more gain in weight than mice fed with regular diet. Similarly, p21-/- mice fed with high fact diet showed significantly increased circulating levels of cholesterol and triglyceride compared to p21-/- mice fed with regular diet and wild type mice fed with high fat diet. The results from gene expression analysis of pro- and anti-atherosclerotic molecules such as TGF-beta, HO-1 and CD36 suggests that high fat diet differentially modulate these genes in p21-/- and wild type mice in favor of atherogenesis. The aortic tissue mRNA of TGF-beta decreased minimally in wild type mice fed with high fat diet but the decrease was significantly more in p21-/- mice fed with high fat diet compared to same mice when fed with regular diet. In sharp contrast, intra aortic CD36 mRNA was significantly higher in p21-/- mice fed with high fat diet compared to same mice fed with regular diet and wild type mice fed with high fat diet. These studies suggest such a sequential relationship between TGF-beta and CD36 in atherosclerosis. CD36 was recognized more than two decades ago as a membrane glycoprotein, initially considered to be a receptor for thrombospondin-1 (TSP-1). However it is now realized to be a multi ligand scavenger because besides TSP-1, its ligands are long-chain fatty acids, modified LDL, retinal photoreceptor outer segments, malarial parasite, malaria-parasitized erythrocytes, sickle erythrocytes, anionic phospholipids, apoptotic cells, and collagens I and IV [26,27]. Among the various activities of CD36 are cell attachment, motility, proliferation, and regulation of protease activity, angiogenesis and above all TGF-beta activation. Therefore, CD36 is also termed as multi-ligand scavenger receptor and one of the important pathologic functions of scavenger receptors, related to foam cell formation and the pathogenesis of atherosclerosis, is recognition and internalization of oxidatively modified LDL. Furthermore, the most compelling data supporting the role for CD36 in foam cell formation and atherosclerosis are from studies with CD36-knockout mice. Macrophages isolated from these animals were found to be defective in uptake of oxLDL and foam cell formation. Also, breeding the CD36 deficient mice with proatherogenic ApoE-/- mice resulted in significant protection of animals from lesion development. Animals fed a Western diet showed a >70% reduction in aortic lesion size and distribution [28]. TGF-beta has been shown to inhibit expression of CD36 [21,29]. A deficiency in TGF-beta, which also results in deficiency of p21 5 could result in increased expression of CD36 leading to severe atherosclerosis. The results from these experiments demonstrate such a reciprocal profile of CD36 and TGF-beta mRNA, suggesting that high fat diet in p21-/- mice tilted the balance towards atherogenesis.
###end p 39
###begin p 40
###xml 122 126 119 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 631 633 628 630 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 759 761 756 758 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 762 764 759 761 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 1120 1122 1117 1119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 1134 1136 1131 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 1137 1139 1134 1136 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 1111 1118 <span type="species:ncbi:9986">rabbits</span>
###xml 1128 1132 <span type="species:ncbi:10090">mice</span>
The analysis of HO-1 mRNA indicate that similar to TGF-beta mRNA expression, its expression decreased significantly in p21-/- mice fed with high fat diet compared to regular diet. The decrease in wild type mice also fed with high fat diet was minimal, suggesting the direct effect of p21 deficiency on HO-1 mRNA expression in aortic tissues of mice fed with high fat diet. HO-1 is an inducible form of heme oxygenase and possesses a variety of adaptive responses against oxidative stress. A number of factors, which include ischemia/reperfusion, hypertension, proinflammatory cytokines, or oxidized LDL, induce expression of HO-1 [30]. The HO reaction involves degradation of heme leading to its conversion to into biliverdin, carbon monoxide, and free iron [31,32]. These events are considered to provide protective roles against stresses in the vascular wall caused by a variety of pathological changes. Oxidative alteration of lipoproteins in vascular wall, which supposedly leads to the initiation and development of atherosclerosis mediate the relationship of HO-1 with atherosclerosis. HO-1 modulation in rabbits [33] and mice [34,35] demonstrated anti-atherogenic effects of HO-1.
###end p 40
###begin p 41
###xml 59 63 59 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 553 555 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 686 690 686 690 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 690 694 <span type="species:ncbi:10090">mice</span>
Our findings that the aortic mRNA expression of HO-1 in p21-/- mice decreases when fed with high fat diet and develop atherosclerosis are of significance, since with reference to atherosclerosis there are functional similarities between p21 and HO-1. Both these molecules promote cell arrest, one of the key step in preventing smooth muscle cell proliferation and atherosclerosis. Furthermore, p21 seems to be of more significance, since growth inhibition and cell-cycle arrest in HO-1 expressing cells was shown to be associated with induction of p21 [21]. Interestingly, HO-1 deficient cells lack or have reduced p21 expression, in the present study, opposite seems to be true, in p21-/- mice, HO-1 expression significantly decreased when fed with high fat diet.
###end p 41
###begin p 42
###xml 47 48 47 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 49 50 49 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 91 95 91 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 418 422 414 418 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 765 769 753 757 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 775 777 763 765 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 778 780 766 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 907 909 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 910 912 890 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 1185 1187 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 1188 1190 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1256 1260 1224 1228 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1482 1484 1446 1448 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 95 99 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
###xml 539 543 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
###xml 819 823 <span type="species:ncbi:10090">mice</span>
###xml 1260 1264 <span type="species:ncbi:10090">mice</span>
###xml 1550 1555 <span type="species:ncbi:9606">human</span>
###xml 1605 1610 <span type="species:ncbi:9606">human</span>
Atherosclerosis is a disease of inflammation. [1-4], in this study; we demonstrate that p21-/- mice when fed with high fat diet developed significantly severe atherosclerosis compared to same mice fed with regular diet or wild type mice fed with high fat diet. To understand if inflammation was responsible in these mice, IFN-gamma mRNA was analyzed in aortic tissues. The results demonstrate that high fat diet in p21-/- mice resulted in significantly increased IFN-gamma mRNA compared to the same mice fed with regular diet or wild type mice fed with high fat diet. These results suggest that p21 deficiency results in an increased inflammatory response to a high fat diet. Exogenous IFN-gamma has been shown to enhance high fat diet induced atherogenesis in ApoE-/- mice [36,37] and IFN-gamma and TNF-alpha knockout mice did not develop severe atherosclerosis when fed with a diet with high cholesterol [38,39]. There is a large body of evidence suggesting a potent role of inflammation in atherosclerosis. T lymphocytes isolated from atherosclerotic plaques were found to have increased expression of IFN-gamma and HLA class II molecules indicating the state of T cell activation [40-42]. Besides IFN-gamma, PPAR-gamma mRNA in the aortic tissues of p21-/- mice increased significantly in response to high fat diet compared to regular diet. Though the precise role of PPAR-gamma in atherosclerosis is not clear, it has been linked to the development of inflammation and studies [43] have shown its increased expression in macrophage foam cells of human atherosclerotic lesions and endothelial cells of human carotid arteries.
###end p 42
###begin p 43
###xml 278 282 278 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox</sup>
###xml 339 343 339 343 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 625 630 625 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox </sup>
###xml 739 744 739 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox </sup>
###xml 751 756 751 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink">phox </sup>
###xml 814 816 814 816 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 927 929 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 930 932 930 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1046 1050 1046 1050 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 592 596 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
Oxidative stress has been shown to be a key factor in the pathogenesis of atherosclerosis. However, there is a lack of sufficient knowledge delineating the precise molecular events and the mediators involved in this process. The gene expression for NADPH oxidase components (p22phox, NOX-1 and Rac-1) was studied in aortic tissues from p21-/- mice fed with high fat diet and compared with same mice fed with regular diet. It is conceivable that the increased activity of NADPH oxidase components reflected by multifold increased mRNA expression contributed to severe atherosclerosis in these mice. Increased expression of p22phox has been associated with increased vascular smooth muscle cell proliferation and increased expression of gp91phox and p22phox mRNA was associated with the severity of atherosclerosis [22]. The results from this study suggest that in the absence of p21, its protective effects on oxidative stress [23,24] are lost that result in increased NADPH oxidase activity i.e. oxidative stress and severe atherosclerosis in p21-/- mice fed with high fat diet compared to the regular diet.
###end p 43
###begin p 44
###xml 92 100 92 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 353 355 353 355 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 583 591 583 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 634 636 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 864 866 864 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 1021 1023 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 1024 1026 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 1422 1424 1422 1424 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 1900 1902 1900 1902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 1989 1991 1989 1991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 2094 2098 2094 2098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2108 2116 2108 2116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
###xml 2314 2318 2314 2318 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 2396 2398 2393 2395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 2940 2944 2937 2941 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 3018 3020 3015 3017 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 3224 3226 3221 3223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 404 407 <span type="species:ncbi:10116">rat</span>
###xml 1591 1594 <span type="species:ncbi:10116">rat</span>
###xml 1836 1839 <span type="species:ncbi:10116">rat</span>
###xml 2098 2102 <span type="species:ncbi:10090">mice</span>
###xml 2295 2299 <span type="species:ncbi:10090">mice</span>
###xml 2318 2322 <span type="species:ncbi:10090">mice</span>
###xml 2944 2948 <span type="species:ncbi:10090">mice</span>
###xml 3012 3016 <span type="species:ncbi:10090">mice</span>
These studies accumulatively provide direct evidence for a potential protective role of p21 in vivo for vascular disorders involving proliferative disorder specifically atherosclerosis. This may be due to aberrant smooth muscle cell proliferation in these mice. p21 has been shown to inhibit both the migration and proliferation of smooth muscle cells [44] and adenovirus mediated p21 gene expression in rat vascular smooth muscle cells inhibited proliferation [45]. Also in a porcine balloon arterial model, adenovirus-mediated transfer of the p21 gene resulted in 35% reduction of in vivo cell proliferation and intimal thickening [46]. The inhibition of p27, another potent cyclin inhibitor, blocked Ang II induced hypertrophy and promoted hyperplasia indicating a role of cell cycle control in the pathogenesis of atherosclerosis and other vascular disorders [47]. These studies indicate a role of cell cycle control and most significantly of p21 in the arrest of cellular growth in atherosclerosis. Our own studies [48,49] have demonstrated that p21 overexpression reduces mitogen-induced lymphocyte proliferation and inflammation, one of the key mediators in the pathogenesis of atherosclerosis. A number of studies have demonstrated the role of p21 as a protective agent in atherosclerosis. Inhibition of Akt pathway resulted in decreased SMC proliferation and decrease in p21 expression abolished this inhibition [50]. These results demonstrated that p21 may be an integral part of the events leading to the inhibition of SMC proliferation. During progesterone-induced inhibition of rat aortic smooth muscle cell proliferation the expression of CDK2 and CDK4 and of p21 and p27 increased. NSAIDs aspirin, sodium salicylate, diclofenac, ibuprofen, indomethacin and sulindac induce a dose-dependent inhibition of proliferation in rat A10 VSMCs and the expression of p21 and p27 were increased [51] and tranilast-mediated inhibition of SMC was due to the increased expression of p21 [52]. Tranilast efficiently inhibited the smooth muscle cell proliferation but not those isolated from p21-/- mice. The in vivo experiments also confirmed the role of p21 in limiting SMC proliferation, since the administration of tranilast significantly reduced the neointimal VSMC hyperplasia in wild-type mice but not in p21-/- mice. IL-beta induced SMC proliferation resulted in decreased p21 expression [53] Statins have been shown to have multiple activities in vascular disorders including atherosclerosis. The inhibition of the mitogen-induced proliferation of microvascular endothelial cell by Cerivastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, which inhibits the biosynthesis of cholesterol and its precursors: farnesyl pyrophosphate and geranylgeranyl pyrophosphate (GGPP) was associated with the increase of p21 expression. Most interestingly adenoviral mediated overexpression of p21 in hypercholesterolemic ApoE-/- mice and resulted in a significant reduction of restenosis in these mice [54]. An inhibition of TSP-1 by a neutralizing A4.1 anti-TSP1 antibody prevented proliferation of serum-stimulated VSMCs. and was followed by a significant induction of p21 expression in A4.1-treated VSMCs [55]. Therefore, the results showed that p21 played an important role in TSP1-mediated control of cellular proliferation.
###end p 44
###begin p 45
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 249 253 249 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 411 413 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 684 686 684 686 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B58">58</xref>
###xml 1063 1065 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 1799 1800 1799 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
In summary these studies suggest that p21 is protective in atherosclerosis, though mechanism of its effect may not be completely clear. Based on our published studies on the anti-inflammatory effects of p21 [56] and the increased inflammation in p21-/- mice, it can be speculated that p21 deficiency in the presence of high fat diet resulted in the development of atherosclerosis. In a number of other studies [57], efficacy of overexpression of p21 as an anti-inflammatory agent has been documented that includes experimental models of arthritis and systemic lupus erythmatosus (SLE). There is only one study with opposite effects than the data presented in this study. The authors [58] showed that p21 is proatherogenic molecule since inactivation of p21 protected against atherosclerosis by stimulating apoptosis, enhancing inflammation etc. However, there is no proven direct relationship between either facilitation of inflammation or phagocytic action of macrophages. Studies have strongly suggested that vascular proliferation and inflammation are linked [59] and coupled with the notion that cell cycle control and inflammation are also connected, makes extremely impossible to think that the deficiency of p21 could result in aggravated atherosclerosis. Initial studies have shown that an initial insult to endothelium results in release of growth factor and cytokines that stimulate the proliferation of smooth muscle cells. Interestingly, proliferation of smooth muscle cells remains one of the key events in the pathophysiology of atherosclerosis. The strongest evidence is provided by the studies demonstrating that the proliferation of SMC is limited as a consequence to the inhibition of cell cycle progression by modulation of p21 or antisense oligonucleotides (ODNs) against c-myc [5]. These studies clearly and directly demonstrate the protective but not the pro-atherogenic properties of p21.
###end p 45
###begin p 46
###xml 665 667 665 667 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
Therefore, based on a large number of supportive studies suggesting multiple positive effects including hematopoiesis, carcinogenesis, nephrotoxicity and inflammation, it is highly unlikely that p21 deficiency will lead to aggravated atherosclerosis. In contrary, p21 deficiency, as observed in this study, will result in increased inflammation and more severe atherosclerosis. Besides, a number of studies, which have demonstrated that modulation of p21 alter cellular proliferation and inflammation, our recent studies have uniquely demonstrated that recombinant p21 protein localizes into nucleus of lymphocytes, inhibit cellular proliferation and inflammation [56]. Therefore, based on the anti-inflammatory and anti-proliferative effects of p21, we speculate a therapeutic role of p21 in limiting the development and progression of atherosclerosis.
###end p 46
###begin title 47
Competing interests
###end title 47
###begin p 48
The author declares that they have no competing interests.
###end p 48
###begin title 49
Acknowledgements
###end title 49
###begin p 50
The author is thankful to Matthew Plummer for excellent technical assistance.
###end p 50
###begin article-title 51
Atherosclerosis - an inflammatory disease
###end article-title 51
###begin article-title 52
Changing concepts of atherogenesis
###end article-title 52
###begin article-title 53
Regulation of immune mechanisms in atherosclerosis
###end article-title 53
###begin article-title 54
Inflammatory mechanisms in atherosclerosis: from laboratory evidence to clinical application
###end article-title 54
###begin article-title 55
Concerted effect of transforming growth factor-beta, cyclin inhibitor p21, and c-myc on smooth muscle cell proliferation
###end article-title 55
###begin article-title 56
TGF-betas and TGF-beta receptors in atherosclerosis
###end article-title 56
###begin article-title 57
A pivotal role for TGF-beta in atherogenesis?
###end article-title 57
###begin article-title 58
Transforming growth factor beta and atherosclerosis: so far, so good for the protective cytokine hypothesis
###end article-title 58
###begin article-title 59
###xml 88 93 <span type="species:ncbi:9606">human</span>
Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development
###end article-title 59
###begin article-title 60
###xml 58 63 <span type="species:ncbi:9606">human</span>
Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins
###end article-title 60
###begin article-title 61
Proteoglycan distribution in lesions of atherosclerosis depends on lesion severity, structural characteristics, and proximity of platelet-derived growth factor and transforming growth factor-beta
###end article-title 61
###begin article-title 62
Genomic instability in the type II TGF-beta 1 receptor gene in atherosclerotic and restenotic vascular cells
###end article-title 62
###begin article-title 63
THP-1 macrophage membrane-bound plasmin activity is up-regulated by transforming growth factor-beta 1 via increased expression of urokinase and the urokinase receptor
###end article-title 63
###begin article-title 64
###xml 84 89 <span type="species:ncbi:9606">human</span>
Increased expression of transforming growth factor-beta1 as a stabilizing factor in human atherosclerotic plaques
###end article-title 64
###begin article-title 65
and Cyclosporine induces the expression of the cyclin inhibitor p21
###end article-title 65
###begin article-title 66
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathway
###end article-title 66
###begin article-title 67
###xml 80 85 <span type="species:ncbi:9606">human</span>
TGF-beta1 down regulates CD36 and scavenger receptor A but upregulates LOX-1 in human macrophages
###end article-title 67
###begin article-title 68
Heme oxygenase-1 protects against vascular constriction and proliferation
###end article-title 68
###begin article-title 69
###xml 67 70 <span type="species:ncbi:10116">rat</span>
Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells
###end article-title 69
###begin article-title 70
###xml 94 98 <span type="species:ncbi:10090">mice</span>
p53-dependent stimulation of redox-related genes in the lymphoid organs of gamma-irradiated - mice identification of Haeme-oxygenase 1 as a direct p53 target gene
###end article-title 70
###begin article-title 71
Inhibition of vascular smooth muscle cell proliferation by chronic hemin treatment
###end article-title 71
###begin article-title 72
###xml 63 68 <span type="species:ncbi:9606">human</span>
Superoxide production and expression of nox family proteins in human atherosclerosis
###end article-title 72
###begin article-title 73
The cyclin-dependent kinase inhibitor p21 protects the lung from oxidative stress
###end article-title 73
###begin article-title 74
The nitroxide tempol induces oxidative stress, p21(WAF1/CIP1), and cell death in HL60 cells
###end article-title 74
###begin article-title 75
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Quantification of atherosclerosis in mice
###end article-title 75
###begin article-title 76
CD36 and atherosclerosis
###end article-title 76
###begin article-title 77
CD36 in atherosclerosis. The role of a class B macrophage scavenger receptor
###end article-title 77
###begin article-title 78
Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species
###end article-title 78
###begin article-title 79
Transforming growth factor-beta1 inhibits macrophage cholesteryl ester accumulation induced by native and oxidized VLDL remnants
###end article-title 79
###begin article-title 80
Heme oxygenase: recent advances in understanding its regulation and role
###end article-title 80
###begin article-title 81
Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications
###end article-title 81
###begin article-title 82
Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?
###end article-title 82
###begin article-title 83
###xml 77 84 <span type="species:ncbi:9986">rabbits</span>
Heme oxygenase-1 inhibits atherogenesis in Watanabe heritable hyperlipidemic rabbits
###end article-title 83
###begin article-title 84
###xml 125 129 <span type="species:ncbi:10090">mice</span>
Adenovirus-mediated heme oxygenase-1 gene transfer inhibits the development of atherosclerosis in apolipoprotein E-deficient mice
###end article-title 84
###begin article-title 85
###xml 84 88 <span type="species:ncbi:10090">mice</span>
Heme oxygenase-1 inhibits atherosclerotic lesion formation in ldl-receptor knockout mice
###end article-title 85
###begin article-title 86
An inflammatory pathway of IFN-gamma production in coronary atherosclerosis
###end article-title 86
###begin article-title 87
###xml 61 65 61 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Exogenous interferon-gamma enhances atherosclerosis in ApoE E-/- mice
###end article-title 87
###begin article-title 88
###xml 56 60 <span type="species:ncbi:10090">mice</span>
IFN-gamma potentiates atherosclerosis in ApoE knock-out mice
###end article-title 88
###begin article-title 89
###xml 39 45 <span type="species:ncbi:10090">murine</span>
Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-gamma knockout recipients
###end article-title 89
###begin article-title 90
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55
###end article-title 90
###begin article-title 91
Immune responses to oxidative neoepitopes on LDL and phospholipids modulate the development of atherosclerosis
###end article-title 91
###begin article-title 92
###xml 19 24 <span type="species:ncbi:9606">human</span>
T lymphocytes from human atherosclerotic plaques recognize oxidized low-density lipoprotein
###end article-title 92
###begin article-title 93
###xml 69 74 <span type="species:ncbi:9606">human</span>
Expression of peroxisome proliferator-activated receptor subtypes in human atherosclerosis
###end article-title 93
###begin article-title 94
Inhibition of smooth muscle cell migration by the p21 cdk inhibitor
###end article-title 94
###begin article-title 95
###xml 171 174 <span type="species:ncbi:10116">rat</span>
Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty
###end article-title 95
###begin article-title 96
Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury
###end article-title 96
###begin article-title 97
A novel role for the cyclin-dependent kinase inhibitor p27 (Kip1) in angiotensin II-stimulated vascular smooth muscle cell hypertrophy
###end article-title 97
###begin article-title 98
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">In vitro </italic>
###xml 13 21 13 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo </italic>
In vitro and in vivo transfection of p21 gene enhances Cyclosporine mediated inhibition of lymphocyte proliferation
###end article-title 98
###begin article-title 99
Reciprocal role of cyclins and cyclin kinase inhibitor p21WAF1/CIP1 on lymphocyte proliferation, allo-immune activation and inflammation
###end article-title 99
###begin article-title 100
Akt controls vascular smooth muscle cell proliferation in vitro and in vivo by delaying G1/S exit
###end article-title 100
###begin article-title 101
Non-steroidal anti-inflammatory drugs (NSAIDs) inhibit vascular smooth muscle cell proliferation via differential effects on the cell cycle
###end article-title 101
###begin article-title 102
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse genetic evidence that tranilast reduces smooth muscle cell hyperplasia via a p21(WAF1)-dependent pathway
###end article-title 102
###begin article-title 103
Interleukin-1beta inhibits expression of p21(WAF1/CIP1) and p27(KIP1) and enhances proliferation in response to platelet-derived growth factor-BB in smooth muscle cells
###end article-title 103
###begin article-title 104
###xml 207 211 <span type="species:ncbi:10090">mice</span>
Mutated p21/WAF/CIP transgene overexpression reduces smooth muscle cell proliferation, macrophage deposition, oxidation-sensitive mechanisms, and restenosis in hypercholesterolemic apolipoprotein E knockout mice
###end article-title 104
###begin article-title 105
###xml 38 43 <span type="species:ncbi:9606">human</span>
Cyclic AMP inhibited proliferation of human aortic vascular smooth muscle cells, accompanied by induction of p53 and p21
###end article-title 105
###begin article-title 106
Recombinant p21 protein inhibits lymphocyte proliferation and transcription factors
###end article-title 106
###begin article-title 107
###xml 36 42 <span type="species:ncbi:10090">murine</span>
A mimic of p21WAF1/CIP1 ameliorates murine lupus
###end article-title 107
###begin article-title 108
Absence of p21Waf1/Cip1/Sdi1 modulates macrophage differentiation and inflammatory response and protects against atherosclerosis
###end article-title 108
###begin article-title 109
A cell-cycle independent role for p21 in regulating synovial fibroblast migration in rheumatoid arthritis
###end article-title 109

